Technical Analysis for PEN - Penumbra, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 201.84 | -3.28% | -6.84 |
Earnings due: Apr 30
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | -3.28% | |
Bollinger Band Squeeze | Range Contraction | -3.28% |
Alert | Time |
---|---|
Down 1 ATR | about 18 hours ago |
Down 3% | about 19 hours ago |
60 Minute Opening Range Breakdown | about 20 hours ago |
Down 2 % | about 23 hours ago |
Fell Below Lower Bollinger Band | about 23 hours ago |
Get a Trading Sidekick!
- Earnings date: 04/30/2024
Penumbra, Inc. Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in United States, Japan, and internationally. The company offers neurovascular access products under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PXSLIM, and Velocity brands; and aspiration-based thrombectomy systems and accessory devices under the Penumbra System brand, as well as stent retriever for mechanical thrombectomy under the 3D brand. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands, as well as neurovascular stents under the LIBERTY Stent brand; neurosurgical tools for the removal of tissue and fluids under the Apollo System brand; detachable embolic coil systems for peripheral embolization under the RUBY Coil brand; detachable, microcatheter-deliverable occlusion devices under the POD (penumbra occlusion device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand. The company sells its products through its salesforce and distributors to hospitals in the neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Health Care Catheter Interventional Radiology Vascular Access Products Neuron Stent Surgical Tools Thrombectomy
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 348.67 |
52 Week Low | 180.93 |
Average Volume | 364,285 |
200-Day Moving Average | 245.89 |
50-Day Moving Average | 236.81 |
20-Day Moving Average | 218.04 |
10-Day Moving Average | 215.87 |
Average True Range | 7.27 |
RSI (14) | 31.51 |
ADX | 28.29 |
+DI | 13.88 |
-DI | 37.00 |
Chandelier Exit (Long, 3 ATRs) | 218.60 |
Chandelier Exit (Short, 3 ATRs) | 222.76 |
Upper Bollinger Bands | 231.24 |
Lower Bollinger Band | 204.85 |
Percent B (%b) | -0.11 |
BandWidth | 12.10 |
MACD Line | -7.35 |
MACD Signal Line | -6.63 |
MACD Histogram | -0.7261 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 213.29 | ||||
Resistance 3 (R3) | 214.27 | 211.43 | 211.38 | ||
Resistance 2 (R2) | 211.43 | 208.52 | 210.94 | 210.75 | |
Resistance 1 (R1) | 206.64 | 206.71 | 205.22 | 205.66 | 210.11 |
Pivot Point | 203.80 | 203.80 | 203.09 | 203.31 | 203.80 |
Support 1 (S1) | 199.00 | 200.88 | 197.58 | 198.02 | 193.57 |
Support 2 (S2) | 196.16 | 199.08 | 195.67 | 192.93 | |
Support 3 (S3) | 191.37 | 196.16 | 192.30 | ||
Support 4 (S4) | 190.39 |